Skip to main content

Welcome message

ECIL 10 meeting

In 2005, we had our first, almost experimental, meeting, initiated by the four participating bodies: the EORTC Infectious Diseases Group, the EBMT Infectious Diseases Working Party, the Supportive Care Group of the ELN, and the Immunocompromised Host Society. Nineteen years later, ECIL has matured, and has earned its place as an authority in advising how best to deal with infectious complications of immunocompromised patients. ECIL has also come of age and is now a non-for profit organization thereby securing its future and safeguarding its autonomy.

ECIL has always sought to include the widest range of specialists in Infectious diseases of the immunocompromised patients be they clinicians, microbiologists, oncologists, haematologists to help define new areas of research. Since its inception, ECIL has published 34 articles in peer reviewed journals and 35 slide sets on a variety of infectious disease topics with the main ones being regularly updated. Thanks to their expertise, we have been able to create, debate, and issue guidelines for the wider community.

For this new edition, we have chosen to address five topics:

  • Update on cytomegalovirus infections,
  • Clostridioides difficile infections in patients with hematological malignancies,
  • Update on antifungal prophylaxis,
  • Update on COVID-19,
  • and Bacterial: new drugs-duration of therapy-febrile neutropenia.

These sessions will be held in Mercure Sophia Antipolis in Nice (France) on September 19-21, 2024. Participation in ECIL 10 is only by invitation by the Organizer Committee, as it has been done from the beginning.

We gratefully acknowledge the support of our sponsors and wish to thank them for their contributions throughout the years.

Enjoy ECIL 10!

Best wishes
The ECIL 10 Organization Committee
Johan Maertens, Thierry Calandra, Simone Cesaro, Catherine Cordonnier, Rafael de la Camara, Peter Donnelly, Hermann Einsele, Raoul Herbrecht, Hans H. Hirsch, Per Ljungman, Georg Maschmeyer